Case 2: Post-transplant diabetes mellitus in renal transplantation

Transplantation

Volumn 71, Issue 12, 2001, Pages 1872-1873

  First, M Roy ^a,b  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^b Medsite Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; OKT 3; PREDNISONE; TACROLIMUS;

ADULT; ALLOGRAFT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIABETES MELLITUS; DISEASE COURSE; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0035958232     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200106270-00030     Document Type: Article

References (11)

1. Post-transplant diabetes mellitus. The role of immunosuppression
2. Cyclosporine and tacrolimus (FK506): A comparison of efficacy and safety profiles
3. Tacrolimus: A further update of its pharmacology and therapeutic use in the management of organ transplantation
4. The role of tacrolimus in adult kidney transplantation: A review
5. Tacrolimus. An update of its pharmacology and clinical efficacy in the management of organ transplantation
6. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation
7. Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: A report of the European Tacrolimus Multicenter Renal Study Group
8. A prospective, randomized trial of tacrolimus/prednisone versus tacrolimus/prednisone/mycophenolate mofetil in renal transplant recipients
9. Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation
10. Low rejection rates with tacrolimus-based dual and triple regimens following renal transplantation
11. Safety and efficacy of tacrolimus in combination with mycophenolate mofetil (MMF) in cadaveric renal transplant recipients